F Mignolet

Radiotherapy in breast-conserving treatment for ductal carcinoma in situ: first results of the EORTC randomised phase III trial 10853

Jean‐Pierre Julien, Nina Bijker, Ian S. Fentiman et al. · The Lancet · 2000 · 510 citations

Surgical Oncology, Radiation Therapy, Medicine +10

Randomized clinical trial to assess the value of breast-conserving therapy in stage I and II breast cancer, EORTC 10801 trial.

van Dongen Ja, Harry Bartelink, Fentiman Is et al. · PubMed · 1992 · 446 citations

Randomized Clinical Trial, Surgical Oncology, Breast Oncology +18

Quality of life of early-stage breast cancer patients treated with radical mastectomy or breast-conserving procedures: results of EORTC trial 10801

Desmond Curran, J P van Dongen, Neil K. Aaronson et al. · European Journal of Cancer · 1998 · 353 citations

Surgical Oncology, Breast-conserving Procedures, Eortc Trial 10801 +10

Factors influencing local relapse and survival and results of salvage treatment after breast-conserving therapy in operable breast cancer: EORTC trial 10801, breast conservation compared with mastectomy in TNM stage I and II breast cancer

J.A. van Dongen, Harry Bartelink, Ian S. Fentiman et al. · European Journal of Cancer · 1992 · 271 citations

Surgical Oncology, Local Relapse, Breast Oncology +10

Prognosis after treatment for loco-regional recurrence after mastectomy or breast conserving therapy in two randomised trials (EORTC 10801 and DBCG-82TM)

Geertjan van Tienhoven, Adri C. Voogd, Johannes L. Peterse et al. · European Journal of Cancer · 1999 · 216 citations

Surgical Oncology, Breast Oncology, Medicine +10